delta 9 tetrahydrocannabinol/cannabis

FIELD OF THE INVENTION This invention relates to ways of extracting and concentrating cannabinoids from plant substrates including hemp, and particularly ways of modifying ratios of various cannabinoids including trans-.DELTA.9-tetrahydrocannabinol (THC), Cannabinol (CBN) and Cannabidiol

CROSS REFERENCE TO RELATED APPLICATIONS This application is a national stage application (under 35 U.S.C. .sctn.371) of PCT/EP2014/063872, filed Jun. 30, 2014, which claims benefit of European Application No. 13182788.3, filed Sep. 3, 2013, the entire contents of which is fully incorporated herein

FIELD OF THE INVENTION The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resveratrol, and

FIELD OF THE INVENTION The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), and at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resvertrol, and

FIELD OF THE INVENTION The present invention pertains to a pharmaceutical composition comprising .DELTA.9 Tetrahydrocannabinol-(THC), Cannabidiol (CBD), and a cytochrome p450 enzyme inhibitor. BACKGROUND OF THE INVENTION Cannabinoids are a group of chemicals from Cannabis Sativa or Cannabis indica

FEDERAL SUPPORT STATEMENT Not Applicable SEQUENCE LISTING Not Applicable BACKGROUND OF THE INVENTION Raw cannabis contains tetrahydrocannabinol carboxylic acid (THC-COOH); this substance is also referred to as THC acid, .DELTA.9-THC acid, THCA-A, or THCA. The article that appears in the Journal of

This application includes material that is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent disclosure, as it appears in the Patent and Trademark Office files or records, but otherwise reserves all copyright rights

This application includes material that is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent disclosure, as it appears in the Patent and Trademark Office files or records, but otherwise reserves all copyright rights

FIELD OF THE INVENTION The present invention relates generally to cannabinoid derivatives of delta-8-tetrahydrocannabinol (.DELTA..sup.8-THC), delta-9-tetrahydrocannabinol (.DELTA..sup.9-THC), and delta-6a-10a-tetrahydrocannabinol (.DELTA..sup.6a-10a-THC) that are active as either agonists or

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a national stage application (under 35 U.S.C. .sctn. 371) of PCT/EP2016/060905, filed May 13, 2016, which is incorporated herein by reference in its entirety. The present invention relates to methods for purifying one or two cannabinoid